Published 12 hours ago • loading... • Updated 7 hours ago
Cognito Reports Pivotal Phase 3 Results for Spectris AD, a Non-Invasive, At-Home Approach for Alzheimer's Treatment, Backed by ADDF Investment
In a yearlong trial of more than 670 participants, the Spectris device slowed decline by 56% in mild cases but not in moderate cases.
Summary by Daily Journal
4 Articles
4 Articles
Reposted by
PressNewsAgency
An intriguing approach to slow Alzheimer’s shows mixed results
The largest trial yet of a headset that delivers flickering light and sound in an attempt to slow the progression of Alzheimer’s has delivered mixed results.
Cognito Reports Pivotal Phase 3 Results for Spectris AD, a Non-Invasive, At-Home Approach for Alzheimer's Treatment, Backed by ADDF Investment
Study misses primary endpoint, but prespecified analysis suggests possible benefit in mild Alzheimer's, pointing to a potential role for devices alongside drugs in future treatment
Coverage Details
Total News Sources4
Leaning Left2Leaning Right0Center1Last Updated67% Left
Bias Distribution
- 67% of the sources lean Left
67% Left
L 67%
C 33%
Factuality
To view factuality data please Upgrade to Premium









